Licensing & Transactions
Regulatory, Advertising & Marketing
B.Sc. (Biology)(Hons.), Queen's University, 2000
Ph.D. (Genetics), University of Toronto, 2006
J.D., University of Toronto, 2008
Admitted to the Ontario Bar, 2009
Registered Canadian Patent Agent, 2014
Registered United States Patent Agent, 2015
Canadian Bar Association (CBA)
Intellectual Property Institute of Canada (IPIC), Affiliate
B.Sc. (Biology)(Hons.), Ph.D. (Genetics), J.D.
Ainslie is a lawyer and registered patent agent in Canada and the United States. Ainslie’s practice focuses on life sciences matters, including patents, licensing, and related litigation. She works closely with clients in preparing and prosecuting patent applications relating to pharmaceuticals, biologics, diagnostics, biotechnology and plant technologies. Ainslie also has experience in the analysis of patent issues such as validity, infringement and freedom to operate. Ainslie has worked on matters involving Food and Drugs Act compliance.
While obtaining her Ph.D. from the University of Toronto, Ainslie conducted research directed to identifying the mode-of-action of small molecules using genomic technologies.
Ainslie has authored a number of professional papers including, "Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast" published in Cell and "The integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways," published in Nature Biotechnology.
Ainslie is the recipient of the CIHR (Canadian Institutes of Health Research) Canada Graduate Scholarship Doctoral Award and the NSERC (Natural Sciences and Engineering Research Council of Canada) Post-Graduate Scholarship.
Ainslie is currently a member of the Rethink Breast Cancer R3 National Advisory Committee.